LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Envafolimab plus chemotherapy in advanced gastric or gastroesophageal junction (G/GEJ) cancer.

Photo by nci from unsplash

e16585Background: Envafolimab is a novel fusion protein of humanized anti-PD-L1 single domain antibody and human IgG1 Fc, formulated for subcutaneously (SC) injection. This study examined the feasi... Click to show full abstract

e16585Background: Envafolimab is a novel fusion protein of humanized anti-PD-L1 single domain antibody and human IgG1 Fc, formulated for subcutaneously (SC) injection. This study examined the feasi...

Keywords: plus chemotherapy; advanced gastric; chemotherapy advanced; gastroesophageal junction; envafolimab plus; gastric gastroesophageal

Journal Title: Journal of Clinical Oncology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.